Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sempoux

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Journal De Radiologie|July 5, 2003
[Multidetector CT and MRI of benign liver tumors]Be Van Beers, Y Horsmans, C Sempoux
European Radiology|September 21, 2000
Angiomyolipoma of the liver: ferumoxides-enhanced MR imagingE Ketelslegers, B E Van Beers, C Sempoux
Diabetes|March 29, 2001
No decrease of the beta-cell mass in type 2 diabetic patientsY Guiot, C Sempoux, P Moulin, et al.
Liver|October 10, 1998
Paracetamol-induced liver toxicity after intravenous administrationY Horsmans, C Sempoux, R Detry, et al.
Acta Gastro-Enterologica Belgica|April 10, 2008
Acute hepatitis with prolonged cholestasis and disappearance of interlobular bile ducts following tibolone and Hypericum perforatum (St. John's wort). Case of drug interaction?F Etogo-Asse, F Boemer, C Sempoux, et al.
Gut|February 18, 2006
Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in ratsI A Leclercq, C Sempoux, P Stärkel, et al.
Liver|February 10, 1998
Acute lobular hepatitis as the first manifestation of recurrent autoimmune hepatitis after orthotopic liver transplantationC Sempoux, Y Horsmans, J Lerut, et al.
Lancet (London, England)|May 29, 1999
Atorvastatin-induced acute hepatitis with absence of cross-toxicity with simvastatinA Nakad, L Bataille, V Hamoir, et al.
Diabetes|March 29, 2001
Human type 2 diabetes: morphological evidence for abnormal beta-cell functionC Sempoux, Y Guiot, D Dubois, et al.
European Journal of Cancer (Oxford, England : 1990)|June 22, 2007
The PPARgamma agonist pioglitazone inhibits early neoplastic occurrence in the rat liverI Borbath, I Leclercq, P Moulin, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Journal De Radiologie|July 5, 2003
[Multidetector CT and MRI of benign liver tumors]Be Van Beers, Y Horsmans, C Sempoux
European Radiology|September 21, 2000
Angiomyolipoma of the liver: ferumoxides-enhanced MR imagingE Ketelslegers, B E Van Beers, C Sempoux
Diabetes|March 29, 2001
No decrease of the beta-cell mass in type 2 diabetic patientsY Guiot, C Sempoux, P Moulin, et al.
Liver|October 10, 1998
Paracetamol-induced liver toxicity after intravenous administrationY Horsmans, C Sempoux, R Detry, et al.
Acta Gastro-Enterologica Belgica|April 10, 2008
Acute hepatitis with prolonged cholestasis and disappearance of interlobular bile ducts following tibolone and Hypericum perforatum (St. John's wort). Case of drug interaction?F Etogo-Asse, F Boemer, C Sempoux, et al.
Gut|February 18, 2006
Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in ratsI A Leclercq, C Sempoux, P Stärkel, et al.
Liver|February 10, 1998
Acute lobular hepatitis as the first manifestation of recurrent autoimmune hepatitis after orthotopic liver transplantationC Sempoux, Y Horsmans, J Lerut, et al.
Lancet (London, England)|May 29, 1999
Atorvastatin-induced acute hepatitis with absence of cross-toxicity with simvastatinA Nakad, L Bataille, V Hamoir, et al.
Diabetes|March 29, 2001
Human type 2 diabetes: morphological evidence for abnormal beta-cell functionC Sempoux, Y Guiot, D Dubois, et al.
European Journal of Cancer (Oxford, England : 1990)|June 22, 2007
The PPARgamma agonist pioglitazone inhibits early neoplastic occurrence in the rat liverI Borbath, I Leclercq, P Moulin, et al.
Pageof 9